What is Aptorum Group Ltd's earnings per share (EPS)?

Aptorum Group Ltd (APM) reported diluted earnings per share of $-0.19 for fiscal year 2025. This represents a 75.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Aptorum Group Ltd Financials

APM

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Aptorum Group Ltd (APM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI APM FY2025 2026-04-22

Aptorum’s visible mechanic is a cost reset supported by external financing rather than a business already paying for itself.

FY2025’s net loss narrowed to -$1.36M from -$4.27M in FY2024, but operating cash flow worsened to -$1.84M from -$1.19M while R&D fell to $353K from $2.20M. That combination says the income statement improved faster than cash use: the company cut spending sharply, yet cash conversion still did not follow, so the business remains dependent on funding outside operations.

Across FY2021-FY2023, R&D exceeded revenue each year, and FY2023 gross profit was only $11K on $431K of revenue. That makes the later narrowing of losses look like a cost reset in a development-stage operating model, not evidence that commercial activity is carrying the business.

Liquidity improved from cash of $874K in FY2024 to $3.45M in FY2025, but that followed $4.42M of financing inflow while the current ratio remained only 0.8x. That combination means near-term obligations still exceed readily available current assets, so day-to-day funding is being bridged by capital raising rather than by internally generated cash.

Financial Health Signals

Financial Profile 2/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Aptorum Group Ltd's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Liquidity

Aptorum Group Ltd's current ratio of 0.78 is below the typical benchmark, resulting in a score of 10/100. However, the company holds substantial cash reserves (75% of current liabilities), which buffers actual liquidity risk. Large mature operators often run tight current ratios by design.

Returns

Aptorum Group Ltd generates a -5.9% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -20.2% the prior year.

Piotroski F-Score Weak

2/9

Aptorum Group Ltd passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality Low Quality

1.35x

For every $1 of reported earnings, Aptorum Group Ltd generates $1.35 in operating cash flow (-$1.8M OCF vs -$1.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

-$1.4M

YoY+68.1%

Aptorum Group Ltd reported -$1.4M in net income in fiscal year 2025. This represents an increase of 68.1% from the prior year.

EPS (Diluted)

$-0.19

YoY+75.6%

Aptorum Group Ltd earned $-0.19 per diluted share (EPS) in fiscal year 2025. This represents an increase of 75.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$3.5M

YoY+295.0%

5Y CAGR-1.0%

Aptorum Group Ltd held $3.5M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

N/A

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

-5.9%

YoY+14.3pp

5Y CAGR-17.7pp

Aptorum Group Ltd's ROE was -5.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 14.3 percentage points from the prior year.

Capital Allocation

R&D Spending

$353K

YoY-83.9%

5Y CAGR-50.3%

Aptorum Group Ltd invested $353K in research and development in fiscal year 2025. This represents a decrease of 83.9% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

APM Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	N/A	$431K-66.7%	$1.3M-15.9%	$1.5M	N/A
Cost of Revenue	N/A	N/A	$421K-65.4%	$1.2M-16.7%	$1.5M	N/A
Gross Profit	N/A	N/A	$11K-86.8%	$80K-2.2%	$82K	N/A
R&D Expenses	$353K-83.9%	$2.2M-57.8%	$5.2M-43.6%	$9.2M-15.2%	$10.9M-6.2%	$11.6M
SG&A Expenses	$573K-14.4%	$669K-65.3%	$1.9M-63.0%	$5.2M-3.5%	$5.4M+11.5%	$4.9M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$1.4M+68.1%	-$4.3M-51.1%	-$2.8M+71.2%	-$9.8M+60.9%	-$25.0M-609.1%	$4.9M
EPS (Diluted)	$-0.19+75.6%	$-0.78-25.8%	$-0.62+77.5%	$-2.75+61.5%	$-7.15-457.5%	$2.00

Metric	Q4'25	Q3'25	Q2'25	Q4'24	Q3'24	Q2'24	Q4'23	Q2'23
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

APM Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$18.7M+15.9%	$16.1M-21.9%	$20.6M-1.1%	$20.9M-4.7%	$21.9M-50.5%	$44.2M
Current Assets	$3.6M+274.4%	$960K-61.2%	$2.5M-65.0%	$7.1M-44.3%	$12.7M-62.3%	$33.7M
Cash & Equivalents	$3.5M+295.0%	$874K-56.4%	$2.0M-60.0%	$5.0M-39.3%	$8.3M+127.9%	$3.6M
Inventory	N/A	N/A	N/A	$28K-22.5%	$36K-8.6%	$39K
Accounts Receivable	N/A	N/A	$48K-72.6%	$174K+121.6%	$79K+26.5%	$62K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	-$4.4M+11.6%	-$5.0M-19.0%	-$4.2M-181.6%	$5.2M+403.2%	-$1.7M-128.0%	$6.1M
Current Liabilities	$4.6M+5.9%	$4.3M+106.7%	$2.1M	N/A	$4.4M+13.1%	$3.9M
Long-Term Debt	N/A	N/A	N/A	$130K-56.2%	$296K0.0%	$296K
Total Equity	$23.1M+9.4%	$21.1M-14.9%	$24.8M+58.1%	$15.7M-33.4%	$23.6M-43.6%	$41.8M
Retained Earnings	-$73.8M-1.9%	-$72.4M-6.3%	-$68.2M-4.3%	-$65.3M-17.6%	-$55.5M-82.2%	-$30.5M

Metric	Q4'25	Q3'25	Q2'25	Q4'24	Q3'24	Q2'24	Q4'23	Q2'23
Total Assets	$18.7M+6.3%	$17.6M-2.9%	$18.1M+12.2%	$16.1M	N/A	$17.7M-14.2%	$20.6M+43.2%	$14.4M
Current Assets	$3.6M+44.9%	$2.5M-17.5%	$3.0M+213.2%	$960K	N/A	$1.5M-38.0%	$2.5M+30.5%	$1.9M
Cash & Equivalents	$3.5M+51.9%	$2.3M-17.6%	$2.8M+215.3%	$874K+15.9%	$755K-3.6%	$783K-61.0%	$2.0M+489.3%	$340K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	$22K-54.3%	$48K-28.1%	$66K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	-$4.4M+10.7%	-$5.0M+1.5%	-$5.0M-0.5%	-$5.0M	N/A	-$5.0M-17.7%	-$4.2M+43.4%	-$7.4M
Current Liabilities	$4.6M+4.0%	$4.4M+338.4%	$1.0M-76.8%	$4.3M	N/A	$1.3M-37.3%	$2.1M+46.4%	$1.4M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$23.1M+2.6%	$22.5M-2.6%	$23.1M+9.5%	$21.1M+68.9%	$12.5M-44.8%	$22.7M-8.8%	$24.8M+13.7%	$21.8M
Retained Earnings	-$73.8M-0.4%	-$73.5M-0.8%	-$72.9M-0.6%	-$72.4M	N/A	-$70.8M-3.9%	-$68.2M+3.8%	-$70.8M

APM Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$1.8M-54.4%	-$1.2M+84.6%	-$7.7M+37.3%	-$12.3M+15.9%	-$14.7M+8.0%	-$15.9M
Capital Expenditures	N/A	N/A	$3K-98.4%	$187K+41.9%	$132K-18.3%	$161K
Free Cash Flow	N/A	N/A	-$7.7M+38.2%	-$12.5M+15.4%	-$14.8M+8.1%	-$16.1M
Investing Cash Flow	N/A	$59K-90.6%	$625K-74.4%	$2.4M-85.2%	$16.5M+796.1%	$1.8M
Financing Cash Flow	$4.4M	N/A	$4.1M-38.2%	$6.6M+138.3%	$2.8M-77.6%	$12.4M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q4'24	Q3'24	Q2'24	Q4'23	Q2'23
Operating Cash Flow	-$536K-10.6%	-$484K	N/A	$120K+519.9%	-$28K	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	$0	$0	N/A	N/A	N/A
Financing Cash Flow	$1.7M	$0	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

APM Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	2.5%-3.7pp	6.2%+0.9pp	5.3%	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	-654.8%+101.4pp	-756.2%+868.4pp	-1624.6%	N/A
Return on Equity	-5.9%+14.3pp	-20.2%-8.8pp	-11.4%+51.0pp	-62.4%+43.7pp	-106.1%-117.9pp	11.8%
Return on Assets	-7.3%+19.2pp	-26.5%-12.8pp	-13.7%+33.3pp	-47.0%+67.4pp	-114.3%-125.5pp	11.1%
Current Ratio	0.78+0.6	0.22-1.0	1.18	N/A	2.90-5.8	8.70
Debt-to-Equity	-0.19+0.0	-0.24-0.1	-0.17-0.2	0.010.0	0.010.0	0.01
FCF Margin	N/A	N/A	-1791.3%-826.3pp	-965.0%-6.2pp	-958.9%	N/A

Metric	Q4'25	Q3'25	Q2'25	Q4'24	Q3'24	Q2'24	Q4'23	Q2'23
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	0.78+0.2	0.56-2.4	2.98+2.8	0.22	N/A	1.17-0.0	1.18-0.1	1.32
Debt-to-Equity	-0.19+0.0	-0.220.0	-0.22+0.0	-0.24	N/A	-0.22-0.0	-0.17+0.2	-0.34
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: The current ratio is below 1.0 (0.78), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Briacell Therapeutics Corp BCTX

$25.3M

CYAD

$14.2M

Biomx Inc PHGE

$8.3M

Biorestorative Therapies Inc BRTX

$5.3M

Leap Therapeutic LPTX

$116.1M

Frequently Asked Questions

Is Aptorum Group Ltd profitable?

No, Aptorum Group Ltd (APM) reported a net income of -$1.4M in fiscal year 2025.

What is Aptorum Group Ltd's return on equity (ROE)?

Aptorum Group Ltd (APM) has a return on equity of -5.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Aptorum Group Ltd's operating cash flow?

Aptorum Group Ltd (APM) generated -$1.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Aptorum Group Ltd's total assets?

Aptorum Group Ltd (APM) had $18.7M in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Aptorum Group Ltd spend on research and development?

Aptorum Group Ltd (APM) invested $353K in research and development during fiscal year 2025.

What is Aptorum Group Ltd's current ratio?

Aptorum Group Ltd (APM) had a current ratio of 0.78 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Aptorum Group Ltd's debt-to-equity ratio?

Aptorum Group Ltd (APM) had a debt-to-equity ratio of -0.19 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Aptorum Group Ltd's return on assets (ROA)?

Aptorum Group Ltd (APM) had a return on assets of -7.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Aptorum Group Ltd's cash runway?

Based on fiscal year 2025 data, Aptorum Group Ltd (APM) had $3.5M in cash against an annual operating cash burn of $1.8M. This gives an estimated cash runway of approximately 23 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Aptorum Group Ltd's Piotroski F-Score?

Aptorum Group Ltd (APM) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Aptorum Group Ltd's earnings high quality?

Aptorum Group Ltd (APM) has an earnings quality ratio of 1.35x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Aptorum Group Ltd?

Aptorum Group Ltd (APM) scores 2 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.